Dothiepin HydrochlorideThird Party Manufacturing in India

Dothiepin Hydrochloride, also known as dosulepin, is a tricyclic antidepressant (TCA) that is structurally related to amitriptyline as its thio analog, where a sulfur atom replaces the carbon-carbon double bond in the central ring. Its antidepressant activity is mediated primarily through inhibition of noradrenaline and serotonin (5-HT) reuptake at the presynaptic nerve terminal. By blocking the norepinephrine transporter (NET) and serotonin transporter (SERT), dothiepin increases the synaptic concentration of these monoamine neurotransmitters, enhancing noradrenergic and serotonergic neurotransmission in the central nervous system.

In addition to its reuptake inhibition, dothiepin exhibits significant antagonist activity at several receptor types. It blocks histamine H1 receptors, contributing to its sedative properties. It antagonizes muscarinic cholinergic receptors, which accounts for anticholinergic side effects such as dry mouth and constipation. Dothiepin also has weak alpha1-adrenoceptor antagonist activity. Its active metabolite, northiaden (nordothiepin), is a selective noradrenaline reuptake inhibitor and contributes substantially to the overall antidepressant effect.

The adaptive changes that occur with chronic dosing — including downregulation of beta-adrenoceptors and sensitization of serotonergic receptors — are believed to underlie the delayed onset of therapeutic action typical of TCAs. Dothiepin also possesses anxiolytic properties, making it particularly useful in depression accompanied by anxiety.

Therapeutic Uses

Dothiepin Hydrochloride is prescribed for the treatment of:

• Major Depressive Disorder: Effective across a wide spectrum of depressive illness, from mild to severe depression, with efficacy equivalent to amitriptyline and imipramine.
• Depression with Anxiety: Particularly valued for its anxiolytic and sedative properties, making it suitable for agitated depression and depression accompanied by significant anxiety.
• Chronic Pain Conditions: Used off-label for psychogenic facial pain, fibromyalgia, and tension-type headaches where its analgesic properties provide additional benefit beyond mood elevation.
• Sleep Disturbances in Depression: The sedative profile helps improve sleep quality in depressed patients with insomnia.

Why Manufacturers Choose Dothiepin Hydrochloride

Dothiepin has been extensively used in clinical practice for over three decades, particularly in the United Kingdom, Australia, New Zealand, and several European and Asian markets. It has a well-established safety profile at therapeutic doses with lower anticholinergic burden compared to amitriptyline. The molecule is commercially available from Indian API manufacturers at competitive prices.

Tablet formulation is straightforward using standard wet granulation or direct compression methods. The three commonly prescribed strengths (25mg, 50mg, and 75mg) allow flexible dosing from initiation through maintenance therapy. Despite the availability of newer antidepressants, dothiepin retains a loyal prescriber base, particularly in the UK and Commonwealth markets, ensuring steady demand. This makes Dothiepin Hydrochloride a reliable molecule for third party manufacturing in India, with consistent demand from PCD franchise operators and export partners in regulated markets.